18 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... characteristic features Clinical ... Active TB: • ... Treatment: Active ... #TB #Diagnosis
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
inhibitors • Injection drug ... characteristic features Clinical ... Active TB: • ... Treatment: Active ... #TB #Diagnosis
Miliary Tuberculosis 
Hematogenous dissemination of Mycobacterium tuberculosis 
Clinical: 
 • Failure to thrive 
 • Fever
Miliary Tuberculosis ... tuberculosis ... Clinical: • Failure ... glands #Miliary #Tuberculosis ... #Diagnosis
Tuberculosis Testing

LATENT TB
• LTBI is diagnosed when an asymptomatic patient has a positive TST or IGRA
Tuberculosis Testing ... result with no clinical ... tuberculosis ... for reactivation tuberculosis ... #ActiveTB #InfectiousDiseases
Lymphadenopathy - Differential Diagnosis Algorithm
Localized: 
 • Cervical: EBV, CMV, HIV, Toxo, TB, Lymphoma, Head /
CMV, HIV, Toxo, TB ... larynx disease, Tuberculosis ... Acute HIV, EBV, Mycobacterial ... - disseminated tuberculosis ... Anti-epileptic drugs
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Tuberculosis Infection ... and molecular diagnostic ... HIV-infected persons with clinical ... #Tuberculosis # ... TB #IDSA #Prevention
Pott's Disease in Tuberculosis - Diagnosis and Management Summary
Epidemiology:
 - Typically from TB endemic areas
 -
Pott's Disease in Tuberculosis ... signs/symptoms of active ... tuberculosis complex ... Potts #Disease #Tuberculosis ... #TB #Diagnosis
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
IDSA - Clinical ... Individualized Treatment ... Resistant Tuberculosis ... MultiDrugResistant #Tuberculosis ... pharmacology #dosing #idsa
Tuberculin Skin Test Interpretation - Threshold for treatment
Induration cutoff >5mm:
 • Recent exposure to an individual
Threshold for treatment ... individual with active ... • Injection drug ... individuals #Tuberculosis ... SkinTest #TST #diagnosis
Approach to chronic meningitis (defined as lasting for 4 weeks or more, and separate from recurrent
of the patient, clinical ... : tuberculosis and ... non-TB mycobacteria ... chronic #meningitis #Differential ... #Diagnosis